ArticleJournal of intensive care2020

Perspective on fibrinolytic therapy in COVID-19: the potential of inhalation therapy against suppressed-fibrinolytic-type DIC.

Hidesaku Asakura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.